Ge HealthCare Technologies Inc. (GEHC) intrinsic value & 10-year financials
Ge HealthCare Technologies Inc. (GEHC) has a Graham intrinsic value of $17.04 per share. At $69.57 on Oct 17, 2026, the stock trades 308% above that value. Over the last 6 fiscal years revenue grew 4.1% a year to $20.6B, with an average return on invested capital of 12.9%.
- Graham intrinsic value
- $17.04
- Share price (Oct 17, 2026)
- $69.57
- Price vs Graham value
- 308% above
- Market cap
- $31.9B
- Revenue (FY2025)
- $20.6B
- Revenue growth (6-yr CAGR)
- 4.1%
- ROIC (10-yr avg)
- 12.9%
- Free cash flow (FY2025)
- $1.5B
GEHC 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $20.6B | $2.1B | $4.55 | $1.5B | 13.4% | 13.8% |
| FY2024 | $19.7B | $2.0B | $4.34 | $1.6B | 13.3% | 14.2% |
| FY2023 | $19.6B | $1.6B | $3.03 | $1.7B | 12.5% | 10.7% |
| FY2022 | $18.3B | $1.9B | $4.22 | $1.8B | 13.8% | 11.9% |
| FY2021 | $17.6B | $2.2B | $4.95 | $1.4B | 15.9% | 14.0% |
| FY2020 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
GE HealthCare Technologies Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
GE HealthCare Technologies Inc. returns on capital have been average, hovering around 12.9% ROIC over the decade.
GE HealthCare Technologies Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, GE HealthCare Technologies Inc. is modeled at -2.1% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $17.04 per share.